Buffer can be a somewhat underrated staple of the pharmaceutical manufacturing process. Large-scale manufacturers can spend, on average, anywhere from $20 to $50 million per year on buffers and “7 out of 10 downstream equipment types with the longest occupancy duration are buffer related. The traditional management of buffers has done little to mitigate key bottlenecks for manufacturers; but innovations in buffer management solutions have begun to surface that help lower costs, improve efficiencies and flexibility, and reduce space and labor requirements. With a more varied array of solutions, it is essential to note the nuances dependent on factors such as the size of the facility, planned scalability, and more.
In this article, you will learn the five most significant considerations when choosing a buffer management solution that will aid manufacturers trying to decide which is suitable for their unique circumstances.